Vaccine News and Research

Latest Vaccine News and Research

Alexion's Soliris Phase 2 clinical study for aHUS meets primary, secondary endpoints

Alexion's Soliris Phase 2 clinical study for aHUS meets primary, secondary endpoints

Celldex presents ACT III Phase 2 clinical trial data for glioblastoma multiforme at SNO Meeting

Celldex presents ACT III Phase 2 clinical trial data for glioblastoma multiforme at SNO Meeting

Vical to present results of Vaxfectin adjuvant at Conference in Hungary

Vical to present results of Vaxfectin adjuvant at Conference in Hungary

Study refocuses on rare group of neutralizing antibodies against HIV

Study refocuses on rare group of neutralizing antibodies against HIV

Discovery could provide new approaches to treat metabolic disorders

Discovery could provide new approaches to treat metabolic disorders

Glenn Foundation awards $60,000 grant to Scripps' scientist for biomedical research

Glenn Foundation awards $60,000 grant to Scripps' scientist for biomedical research

Improving immune system to defend against HIV infection

Improving immune system to defend against HIV infection

Medicare committee recommends expensive drug for some prostate-cancer patients

Medicare committee recommends expensive drug for some prostate-cancer patients

Cholera confirmed in Florida woman who traveled to Haiti

Cholera confirmed in Florida woman who traveled to Haiti

Expert panel to endorse newly approved therapeutic vaccine for advanced prostate cancer

Expert panel to endorse newly approved therapeutic vaccine for advanced prostate cancer

Circassia announces positive result from phase II T-cell vaccine study for house dust mite allergy

Circassia announces positive result from phase II T-cell vaccine study for house dust mite allergy

CDC data: Adults remain unvaccinated against preventable infectious illnesses

CDC data: Adults remain unvaccinated against preventable infectious illnesses

FIP's PSWC and AAPS Annual Meeting to highlight targeted inhalable dry powder HPV vaccine

FIP's PSWC and AAPS Annual Meeting to highlight targeted inhalable dry powder HPV vaccine

Scientists solve structure of key protein from Lassa virus

Scientists solve structure of key protein from Lassa virus

Accentia and Biovest exit Chapter 11 as fully restructured organizations

Accentia and Biovest exit Chapter 11 as fully restructured organizations

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

Researchers reveal mechanism of early-stage anthrax infection

Researchers reveal mechanism of early-stage anthrax infection

Idera presents data on TLR7, TLR9 antagonist candidate for hyperlipidemia at American Heart Association

Idera presents data on TLR7, TLR9 antagonist candidate for hyperlipidemia at American Heart Association

BioSante announces sale of oncolytic virus technology to Cold Genesys

BioSante announces sale of oncolytic virus technology to Cold Genesys

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.